RAPH Raphael Pharmaceutical Inc.

RAPH financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1415397 Exchange: OTC SIC: 2833 (Medicinal Chemicals & Botanical Products) Latest filing: 10-Q filed Aug 14, 2026 Data checked: Oct 21, 2026
Showing 3 of 6 annual and 0 of 23 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$9.43M (Jun 2025)
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Incorporated
NV
Fiscal Year End
December (1231)
Phone
702-442-1166
EIN
260204284
Headquarters
LAS VEGAS, NV, 89108
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: Easy Energy Inc (2007–2021)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
-
Net Income
$-980.00K
Total Assets
$7.00K
Total Equity
$-1.89M
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
52%
Return on Assets
-14000%
Current Ratio
0x
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Raphael Pharmaceutical Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
OPERATING EXPENSES
R&D Expense $631.00K $776.00K $569.00K
SG&A Expense $614.00K $733.00K $763.00K
Operating Income $-1.25M $-1.51M $-1.33M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $-34.00K $-10.00K $-12.00K
Net Income $-1.28M $-1.52M $-1.34M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.07 $0.08 $0.08
Diluted Shares 19.55M 18.67M 16.72M
Balance Sheet
ASSETS
Cash & Equivalents $45.00K $19.00K $230.00K
Accounts Receivable $2.00K $2.00K -
Other Current Assets $6.00K $6.00K $7.00K
Current Assets $51.00K $25.00K $237.00K
PP&E (Net) $2.00K $2.00K $2.00K
Intangible Assets - - $2.00K
Noncurrent Assets $2.00K $2.00K $2.00K
Total Assets $53.00K $27.00K $239.00K
LIABILITIES
Accounts Payable $163.00K $125.00K $69.00K
Short-term Debt - $41.00K -
Other Current Liabilities (derived) $297.70K $603.00K -
Current Liabilities $1.49M $769.00K $132.00K
Noncurrent Liabilities $0 $0 $0
Total Liabilities $1.49M $769.00K $132.00K
EQUITY
Common Stock $202.00K $187.00K $185.00K
Additional Paid-in Capital $8.53M $7.96M $7.39M
Retained Earnings $-10.17M $-8.89M $-7.37M
Total Equity $-1.43M $-742.00K $107.00K
Total Liabilities & Equity $53.00K $27.00K $239.00K
SUPPLEMENTAL
Shares Outstanding 20.18M 18.70M 18.50M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-210.00K $-532.00K $-1.20M
Capital Expenditures - - -
Cash from Investing $0 $0 $0
Cash from Financing $236.00K $321.00K $1.15M
Free Cash Flow - - -
Beginning Cash (CFS) $19.00K $230.00K $288.00K
Net Change in Cash $26.00K $-211.00K $-58.00K
Effect of FX on Cash - - -
Calculated Ending Cash $45.00K $19.00K $230.00K
Cash per BS $45.00K $19.00K $230.00K
Cash scope difference (CFS − BS) - - -
Cash per CFS $45.00K $19.00K $230.00K

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

Is Raphael Pharmaceutical Inc. profitable?

No. Raphael Pharmaceutical Inc. reported $-980.00K in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.